Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

P15-Tat

 
National Institutes of Health

Related topics

Related topics

1 relation
CIGB-300

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity
CIGB-300, formerly known as P15-tat, is a proapoptotic peptide with established antiproliferative activity in vitro and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice.
The antitumor efficacy of the CK2 inhibitors so far described has not been extensively evaluated in cancer animal models. We have… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
Protein Kinase CK2 is a serine-threonine kinase frequently deregulated in many human tumors. Here, we hypothesized that a peptide… Expand
  • figure 2
  • figure 1
  • table 1
  • figure 3
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE